Perennial Allergic Conjunctivitis
📧 Sign up to get email alerts when something new happens for Perennial Allergic Conjunctivitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-04-15FDA Approved: PATADAY ONCE DAILY RELIEF — Supplemental Application (Alcon Laboratories, Inc.)
FDA approved a supplemental application for PATADAY ONCE DAILY RELIEF (olopatadine hydrochloride) from Alcon Laboratories, expanding the lab…
-
FDA approval · 2024-12-18FDA Approved: OLOPATADINE HYDROCHLORIDE — Original Application (Somerset Therapeutics, LLC)
FDA approved Somerset Therapeutics' original application for olopatadine hydrochloride ophthalmic solution as a generic treatment for allerg…
-
CLINICAL_TRIALS trial_result · 2015-10-08Clinical Trial Update: AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis [Phase 3]
Phase 3 trial of AGN-229666 ophthalmic solution for seasonal or perennial allergic conjunctivitis has completed with results posted.
-
FDA approval · 2007-04-26FDA Approved: PATADAY ONCE DAILY RELIEF — Supplemental Application (Alcon Laboratories, Inc.)
FDA supplemental approval granted for Pataday Once Daily Relief with olopatadine hydrochloride, expanding labeling for once-daily dosing in …